| Name | phenformin | 
|---|---|
| Synonyms | 
                                
                                [3H]-Phenformin
                                
                                
                                 Fenformin Normoglucina 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine [14C]-Phenformin 1-phenethylbiguanide MFCD00035039 Imidodicarbonimidic diamide, N-(2-phenylethyl)- Feguanide Phenforminum phenylethyl biguanide phenethylbiguanide Phenformine EINECS 204-057-4 phenformin Cronoformin Fenfoduron Fenformina N-(2-Phenylethyl)imidodicarbonimidic diamide  | 
                        
| Description | Phenformin (1-phenethylbiguanide) is an orally active antidiabetic and anticancer agent. Phenformin has an incidence of associated lactic acidosis. Phenformin acts through acting AMPK activation and blocking mTOR pathway. Phenformin is also a substrate of P-glycoprotein (P-gp), and an OXPHOS inhibitor. Phenformin induces cancer cell apoptosis[1][2]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 332.2±35.0 °C at 760 mmHg | 
| Melting Point | 280-282°C | 
| Molecular Formula | C10H15N5 | 
| Molecular Weight | 205.260 | 
| Flash Point | 154.7±25.9 °C | 
| Exact Mass | 205.132751 | 
| PSA | 97.78000 | 
| LogP | -0.60 | 
| Vapour Pressure | 0.0±0.7 mmHg at 25°C | 
| Index of Refraction | 1.620 | 
| Storage condition | 2-8°C | 
                                CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  | 
                        
| Hazard Codes | Xn: Harmful; | 
|---|---|
| Risk Phrases | R22 | 
| Safety Phrases | S36 | 
| WGK Germany | 3 | 
| RTECS | DU2200000 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~84%  
                                    114-86-3  | 
                        
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 8 p. 2305 - 2313 | 
| 
                                
                                
                                
                                
                                 ~%  
                                    114-86-3  | 
                        
| Literature: Journal of the American Chemical Society, , vol. 81, p. 2220,2223 | 
| Precursor 2 | |
|---|---|
| DownStream 1 | |